Six-month antibody response to SARS-CoV-2 in healthcare workers assessed by virus neutralization and commercial assays
Since the SARS-CoV-2 emergence in December 2019, one of the major concerns has been the duration of immune protection after a first episode. This question is of paramount importance for healthcare workers (HCWs), who are a highly exposed population and among the first targets of vaccination programm...
Gespeichert in:
Veröffentlicht in: | Clinical microbiology and infection 2021-06, Vol.27 (6), p.933-935 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Since the SARS-CoV-2 emergence in December 2019, one of the major concerns has been the duration of immune protection after a first episode. This question is of paramount importance for healthcare workers (HCWs), who are a highly exposed population and among the first targets of vaccination programmes. To date, the persistence of SARS-CoV-2 antibodies in HCWs 6 months after disease onset (ADO) has not been studied with both a virus neutralisation btest and commercial assays. |
---|---|
ISSN: | 1198-743X 1469-0691 |
DOI: | 10.1016/j.cmi.2021.01.003 |